Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents
- PMID: 37319239
- PMCID: PMC10270347
- DOI: 10.1371/journal.pone.0279660
Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents
Abstract
Background: Monitoring COVID-19 infection risk in the general population is a public health priority. Few studies have measured seropositivity using representative, probability samples. The present study measured seropositivity in a representative population of Minnesota residents prior to vaccines and assess the characteristics, behaviors, and beliefs of the population at the outset of the pandemic and their association with subsequent infection.
Methods: Participants in the Minnesota COVID-19 Antibody Study (MCAS) were recruited from residents of Minnesota who participated in the COVID-19 Household Impact Survey (CIS), a population-based survey that collected data on physical health, mental health, and economic security information between April 20 and June 8 of 2020. This was followed by collection of antibody test results between December 29, 2020 and February 26, 2021. Demographic, behavioral, and attitudinal exposures were assessed for association with the outcome of interest, SARS-CoV-2 seroprevalence, using univariate and multivariate logistic regression.
Results: Of the 907 potential participants from the CIS, 585 respondents then consented to participate in the antibody testing (64.4% consent rate). Of these, results from 537 test kits were included in the final analytic sample, and 51 participants (9.5%) were seropositive. The overall weighted seroprevalence was calculated to be 11.81% (95% CI, 7.30%-16.32%) at of the time of test collection. In adjusted multivariate logistic regression models, significant associations between seroprevalence and the following were observed; being from 23-64 and 65+ age groups were both associated with higher odds of COVID-19 seropositivity compared to the 18-22 age group (17.8 [1.2-260.1] and 24.7 [1.5-404.4] respectively). When compared to a less than $30k annual income reference group, all higher income groups had significantly lower odds of seropositivity. Reporting practicing a number of 10 (median reported value in sample) or more of 19 potential COVID-19 mitigation factors (e.g. handwashing and mask wearing) was associated with lower odds of seropositivity (0.4 [0.1-0.99]) Finally, the presence of at least one household member in the age range of 6 to 17 years old was associated with higher odds of seropositivity (8.3 [1.2-57.0]).
Conclusions: The adjusted odds ratio of SARS-CoV-2 seroprevalence was significantly positively associated with increasing age and having household member(s) in the 6-17 year age group, while increasing income levels and a mitigation score at or above the median were shown to be significantly protective factors.
Copyright: © 2023 Abhold et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
No competing interests.
Similar articles
-
Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.Swiss Med Wkly. 2022 May 24;152:w30173. doi: 10.4414/smw.2022.w30173. eCollection 2022 May 23. Swiss Med Wkly. 2022. PMID: 35748747
-
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022. Front Public Health. 2022. PMID: 36276377 Free PMC article.
-
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18. Microbiol Spectr. 2021. PMID: 34406813 Free PMC article.
-
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review.Int J Environ Res Public Health. 2022 Sep 15;19(18):11629. doi: 10.3390/ijerph191811629. Int J Environ Res Public Health. 2022. PMID: 36141897 Free PMC article. Review.
-
Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance.Epidemics. 2022 Dec;41:100645. doi: 10.1016/j.epidem.2022.100645. Epub 2022 Oct 20. Epidemics. 2022. PMID: 36308993 Free PMC article. Review.
Cited by
-
Diagnostic utility of real-time RT-PCR for chikungunya virus detection in the acute phase of infection: a retrospective study.Ann Med. 2025 Dec;57(1):2523559. doi: 10.1080/07853890.2025.2523559. Epub 2025 Jun 26. Ann Med. 2025. PMID: 40570284 Free PMC article.
-
SARS-CoV-2 Seroprevalence Survey in Grocery Store Workers-Minnesota, 2020-2021.Int J Environ Res Public Health. 2022 Mar 16;19(6):3501. doi: 10.3390/ijerph19063501. Int J Environ Res Public Health. 2022. PMID: 35329187 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous